SCHEMBL485288

SCHEMBL485288

O=C(c1ccc2c(c1)C(N(C(=O)c1ccccc1Cl)C1CC1)CC2)N1CCC2(CCN(Cc3cc(F)ccc3F)CC2)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 11/20 0.40
CYP3A4 P08684 8/20 0.39
ALDH1A1 P00352 6/20 0.39
MAPK1 P28482 1/20 0.39
TSHR P16473 6/20 0.38
CYP1A2 P05177 3/20 0.38
HPGD P15428 2/20 0.38
RIPK1 Q13546 1/20 0.37
USP2 O75604 5/20 0.37
CCR8 P51685 2/20 0.37
KCNH2 Q12809 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
RECQL P46063 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484397 0.94 CYP2D6 (0.39) CYP2D6CYP3A4ALDH1A1MAPK1TSHR
SCHEMBL2816549 0.94 CYP2D6 (0.39) CYP2D6CYP3A4ALDH1A1MAPK1TSHR
SCHEMBL484684 0.92 CYP2D6 (0.43) CYP2D6CYP3A4ALDH1A1MAPK1TSHR
SCHEMBL484872 0.90 CYP2D6 (0.39) CYP2D6CYP3A4ALDH1A1MAPK1TSHR
SCHEMBL484434 0.90 CYP2D6 (0.39) CYP2D6CYP3A4MAPK1TSHRCYP1A2
SCHEMBL2820483 0.89 CYP2D6 (0.38) CYP2D6CYP3A4ALDH1A1MAPK1TSHR
SCHEMBL484672 0.88 CYP2D6 (0.42) CYP2D6CYP3A4ALDH1A1MAPK1TSHR
SCHEMBL484380 0.88 HSD11B1 (0.40) CYP2D6CYP3A4ALDH1A1MAPK1TSHR
SCHEMBL485749 0.87 HSD11B1 (0.43) CYP2D6CYP3A4ALDH1A1MAPK1TSHR
SCHEMBL485006 0.87 CYP2D6 (0.42) CYP2D6CYP3A4ALDH1A1MAPK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CYP2D6 1926/4885CYP3A4 3781/4885ALDH1A1 2086/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CYP2D6 1926/4885CYP3A4 3781/4885ALDH1A1 2086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.